Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
FAT4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ERVH-6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors
ANTXR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
TNFAIP8L2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RNF141 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TNNI1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MDM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CNGB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRIM32 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
COMP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM50A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IL20RA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC26A7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PAPPA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MID2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CRIPT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IRF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on